Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NP272018A94

Alpha-parvin/Actopaxin Antibody (OTI1C10), Alexa Fluor™ 594, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals NBP272018AF594

Catalog No. NP272018A94


Only null left
Add to Cart

Description

Description

Alpha-parvin/Actopaxin Monoclonal specifically detects Alpha-parvin/Actopaxin in Human, Mouse, Rat, Canine, Monkey samples. It is validated for Western Blot, Immunohistochemistry, Immunocytochemistry/Immunofluorescence.
Specifications

Specifications

Alpha-parvin/Actopaxin
Monoclonal
Alexa Fluor 594
50 mM sodium borate with 0.05% sodium azide
PARVA
Full length recombinant protein of human Alpha-parvin/Actopaxin (NP_060692) produced in HEK293T cells.
0.1 mL
Primary
Human, Mouse, Rat, Canine, Monkey
IgG2a
Western Blot, Immunohistochemistry, Immunocytochemistry, Immunofluorescence
OTI1C10
Western Blot, Immunohistochemistry, Immunocytochemistry/Immunofluorescence
actopaxin, alpha-parvin, Calponin-like integrin-linked kinase-binding protein, CH-ILKBP, FLJ10793, FLJ12254, FLJ25106, FLJ46049, Matrix-remodeling-associated protein 2, matrix-remodelling associated 2, MXRA2, parvin, alpha
Mouse
Affinity Purified
Phospho Specific
55742.0
Store at 4°C in the dark.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.